|
RCAN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.202100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.203900E-02 |
| Normal-vs-Stage2 |
9.719200E-03 |
| Normal-vs-Stage3 |
1.561210E-03 |
| Normal-vs-Stage4 |
1.212210E-02 |
| Stage1-vs-Stage2 |
1.716390E-01 |
| Stage1-vs-Stage3 |
4.063600E-02 |
| Stage1-vs-Stage4 |
1.857850E-01 |
| Stage2-vs-Stage3 |
9.041000E-01 |
| Stage2-vs-Stage4 |
9.526400E-01 |
| Stage3-vs-Stage4 |
8.471200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.419510E-02 |
| Normal-vs-AfricanAmerican |
1.864640E-01 |
| Normal-vs-Asian |
4.395700E-02 |
| Caucasian-vs-AfricanAmerican |
6.786000E-01 |
| Caucasian-vs-Asian |
9.970400E-01 |
| AfricanAmerican-vs-Asian |
7.021600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.443700E-02 |
| Normal-vs-Female |
1.882220E-02 |
| Male-vs-Female |
9.822600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.738400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.983800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.015200E-03 |
| Normal-vs-Age(81-100Yrs) |
2.242200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.826200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.619690E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.535380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.200800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.732800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.503000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.382200E-02 |
| Classical-VS-Follicular |
3.884400E-01 |
| Classical-VS-Other |
7.111600E-01 |
| Classical-VS-Normal |
6.177900E-02 |
| Tall-VS-Follicular |
4.946000E-01 |
| Tall-VS-Other |
7.286800E-01 |
| Tall-VS-Normal |
5.417300E-03 |
| Follicular-VS-Other |
9.731200E-01 |
| Follicular-VS-Normal |
2.318200E-02 |
| Other-VS-Normal |
2.204000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.180400E-02 |
| Normal-vs-N1 |
2.391500E-04 |
| N0-vs-N1 |
5.347800E-02 |
|
|
